Author:
Source
DaVita (DVA) stock soars as Novo Nordisk’s study shows that although weight-loss drug reduces death risk for chronic kidney disease patients, demand for dialysis services will remain.
Davita (DVA) Shares Gain This Week: Will the Rally Continue?
- by HMG
Tags:investing